Glimpse Group director granted 283K stock options
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Glimpse Group, Inc. director Brian Archer received a grant of stock options covering 283,012 shares of common stock on July 10, 2026. The options have a $0.77 exercise price, expire on July 10, 2036, and vest in equal monthly installments over one year. After this grant, Archer directly holds these options, a warrant over 75,000 shares at a $0.55 exercise price, and 60,000 shares of common stock.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) F1 | 283,012 | $0.00 | $0.00 |
| Holding | Warrant (Right to Buy) | -- | -- | -- |
| Holding | Common Stock | -- | -- | -- |
Footnotes (1)
- F1. This option vests in equal monthly installments over a one-year period commencing on the grant date.
Key Figures
Key Terms
Stock Option (Right to Buy) financial
Warrant (Right to Buy) financial
underlying security financial
vests in equal monthly installments financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did GGRP director Brian Archer report?
What are the key terms of Brian Archer’s GGRP stock option grant?
What warrant position in GGRP does Brian Archer report?
Is Brian Archer’s GGRP option grant reported under a Rule 10b5-1 plan?
What is the vesting schedule for Brian Archer’s new GGRP options?
AI-generated analysis. How Rhea-AI works. Not financial advice.